[Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%]

J Fr Ophtalmol. 2010 Dec;33(10):710-4. doi: 10.1016/j.jfo.2010.09.019. Epub 2010 Nov 18.
[Article in French]

Abstract

Introduction: iterative penetrating keratoplasty procedures (PKPs) increase the risk of graft rejection. Surgeons are reluctant to perform a third procedure following two previous graft failures. We evaluated the outcomes of patients who had three successive PKPs treated with a local combination of cyclosporin 2% A and dexamethasone 0.1% eye drops.

Patients and methods: this is a retrospective study of a series of cases including 15 eyes of 15 patients treated and followed in the ophthalmology unit at the Hôtel-Dieu Hospital in Paris (2006-2009).

Results: after an average follow-up of 20.5±2 months, the risk of transplant rejection was 13.33% and the duration of follow-up corresponded in all patients to the duration of treatment with cyclosporin eye drops. The treatment was not interrupted by any patient because of intolerance.

Conclusion: in this study, we observed a success rate justifying the indication of the third keratoplasty under local cyclosporin 2% classically considered debatable.

Publication types

  • English Abstract

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Corneal Transplantation / statistics & numerical data*
  • Cyclosporine / administration & dosage*
  • Female
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Immunosuppressive Agents
  • Cyclosporine